Topic: How To Invest

Power Growth Investor Hotline – Friday, January 31, 2025

Article Excerpt

THERMO FISHER SCIENTIFIC INC., $597.75, is a buy. The stock (symbol TMO on New York) lets you tap a leading manufacturer of scientific instruments, laboratory equipment, diagnostic consumables, and life science reagents. The shares are now up 83.5% for our subscribers since we first recommended the stock in the May 2020 issue of Power Growth Investor at $325.83 a share. We still think they have room to move higher. In the quarter ended December 31, 2024, Thermo Fisher’s revenue rose 4.7%, to $11.40 billion from $10.89 billion a year earlier. Excluding one-time items, per-share earnings climbed 7.6%, to $6.10 from $5.67. Overall, Thermo Fisher has relied on acquisitions for growth; it also has a high p/e and low yield. That combination leaves the company’s shares vulnerable to a sharp setback on bad corporate news or overall stock market weakness. Still, the company’s success with health technology could produce substantial gains. Thermo Fisher Scientific is a buy. Thermo Fisher recent coverage: January 2025 Issue Hotline for…